4586.T
Price:
$114
Market Cap:
$6.53B
MedRx Co., Ltd, a pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan. The company develops medicines based on Ionic liquid transdermal system (ILTS) and Nano-sized Colloid Transdermal System (NCTS); and researches and develops painless transdermal administration system for vaccines, nucleic acid medicines, protein medicines, etc. Its products pipeline includes MRX-4TZT, which is in phase I clinical trials for the treatment of spastic paralysis; MRX-9FLT that is in phase I clinical trials to treat chronic, cancer, and severe pain; and MRX-7MLL and MRX-6LDT that is in pre-clinical trials to treat Alzheimer's disease...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2013-02-14
Stock Exchange
JPX
Ticker
4586.T
According to MedRx Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -8.53. This represents a change of 155.30% compared to the average of -3.34 of the last 4 quarters.
The mean historical PE Ratio of MedRx Co., Ltd over the last ten years is -3.36. The current -8.53 PE Ratio has changed 25.31% with respect to the historical average. Over the past ten years (40 quarters), 4586.T's PE Ratio was at its highest in in the June 2024 quarter at 27.05. The PE Ratio was at its lowest in in the March 2024 quarter at -10.36.
Average
-3.36
Median
-2.83
Minimum
-5.63
Maximum
-2.17
Discovering the peaks and valleys of MedRx Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 159.84%
Maximum Annual PE Ratio = -2.17
Minimum Annual Increase = -21.51%
Minimum Annual PE Ratio = -5.63
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -4.42 | -21.51% |
| 2023 | -5.63 | 159.84% |
| 2022 | -2.17 | -15.93% |
| 2021 | -2.58 | -16.12% |
| 2020 | -3.08 | 35.88% |
The current PE Ratio of MedRx Co., Ltd (4586.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-4.08
5-year avg
-3.58
10-year avg
-3.36
MedRx Co., Ltd’s PE Ratio is less than OncoTherapy Science, Inc. (-7.06), less than Solasia Pharma K.K. (-3.85), less than WDB coco Co., Ltd. (7.50), less than Modalis Therapeutics Corporation (-2.93), greater than K Pharma,Inc. (-8.59), greater than Noile-Immune Biotech Inc. (-10.07), less than BrightPath Biotherapeutics Co., Ltd. (-4.40), less than SymBio Pharmaceuticals Limited (-1.01), less than TMS Co., Ltd. (-8.13), less than Nippon Chemiphar Co., Ltd. (13.96),
| Company | PE Ratio | Market cap |
|---|---|---|
| -7.06 | $7.11B | |
| -3.85 | $8.44B | |
| 7.50 | $6.27B | |
| -2.93 | $4.85B | |
| -8.59 | $7.43B | |
| -10.07 | $6.97B | |
| -4.40 | $4.63B | |
| -1.01 | $4.88B | |
| -8.13 | $6.10B | |
| 13.96 | $5.51B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MedRx Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MedRx Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MedRx Co., Ltd's PE Ratio?
How is the PE Ratio calculated for MedRx Co., Ltd (4586.T)?
What is the highest PE Ratio for MedRx Co., Ltd (4586.T)?
What is the 3-year average PE Ratio for MedRx Co., Ltd (4586.T)?
What is the 5-year average PE Ratio for MedRx Co., Ltd (4586.T)?
How does the current PE Ratio for MedRx Co., Ltd (4586.T) compare to its historical average?